The Indian Council of Medical Research (ICMR) issued a press release clarifying its process for fast-tracking the development of an indigenous COVID-19 vaccine candidate. The council emphasized that clinical trials are being conducted in accordance with globally accepted norms to expedite the process while maintaining safety and regulatory standards. The Drugs Controller General of India has granted permission for phase 1 and 2 human clinical trials following successful preclinical studies. ICMR stated that the initiative aims to cut unnecessary administrative delays without bypassing essential scientific rigour. The organization reaffirmed its commitment to public health and the safety of the Indian population.

The Indian Council of Medical Research (ICMR) issued a press release clarifying its process for fast-tracking the development of an indigenous COVID-19 vaccine candidate. The council emphasized that clinical trials are being conducted in accordance with globally accepted norms to expedite the process while maintaining safety and regulatory standards. The Drugs Controller General of India has granted permission for phase 1 and 2 human clinical trials following successful preclinical studies. ICMR stated that the initiative aims to cut unnecessary administrative delays without bypassing essential scientific rigour. The organization reaffirmed its commitment to public health and the safety of the Indian population.